P2RY6 and prostate adenocarcinoma: The results revealed that apart from the aforementioned tumors, P2RY6 was also highly expressed in CESC (cervical squamous cell carcinoma and endocervical adenocarcinoma), GBM (glioblastoma multiforme), COAD (colon adenocarcinoma), LAML (acute myeloid leukemia), PAAD (pancreatic adenocarcinoma), OV (ovarian serous cystadenocarcinoma), LGG (brain lower grade glioma), PRAD (prostate adenocarcinoma), SKCM (skin cutaneous melanoma), and TGCT (testicular germ cell tumors) (Fig. 1B, all p < 0.01).